Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
SaleCommon Stock | 12,032 | $100.13 | $1,204,764.16 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 5 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,090.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
SaleCommon Stock | 27,166 | $100.13 | $2,720,131.58 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 4 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionCommon Stock | 27,166 | $58.34 | $1,584,864.44 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 3 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,288.9607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
SaleCommon Stock | 16,161 | $100.13 | $1,618,200.93 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionCommon Stock | 16,161 | $54.19 | $875,764.59 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,283.9607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2022 Filed Apr 5, 2022 23:36 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 2,179 | $101.09 | $220,275.11 |
DisclosureSEC source: 0001127602-22-011639 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,676.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan. Read SEC document |
| April 03, 2022 Filed Apr 5, 2022 23:39 UTC |
Moriarty Thomas MEVP & General Counsel
|
Tax withholdingCommon Stock | 3,556 | $101.09 | $359,476.04 |
DisclosureSEC source: 0001127602-22-011640 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,349 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:35 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
GrantStock Option · Derivative | 51,975 | $101.09 Strike: $101.09 | $5,254,152.75 |
DisclosureSEC source: 0001127602-22-011602 · form4.xml · derivative · entry 7 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,975 Underlying: Common Stock · 51,975 shares Expires 2032-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:35 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Tax withholdingCommon Stock | 3,856 | $101.09 | $389,803.04 |
DisclosureSEC source: 0001127602-22-011602 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122.9607 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:35 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Tax withholdingCommon Stock | 13,532 | $101.09 | $1,367,949.88 |
DisclosureSEC source: 0001127602-22-011602 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,181.9607 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:37 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
GrantStock Option · Derivative | 21,829 | $101.09 Strike: $101.09 | $2,206,693.61 |
DisclosureSEC source: 0001127602-22-011604 · form4.xml · derivative · entry 3 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,829 Underlying: Common Stock · 21,829 shares Expires 2032-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:43 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
GrantStock Option · Derivative | 25,987 | $101.09 Strike: $101.09 | $2,627,025.83 |
DisclosureSEC source: 0001127602-22-011608 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,987 Underlying: Common Stock · 25,987 shares Expires 2032-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 6,756 | $101.09 Strike: $101.09 | $682,964.04 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · derivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,756 Underlying: Common Stock · 6,756 shares Expires 2032-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 3,214 | $101.09 | $324,903.26 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,824 Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 2,740 | $101.09 | $276,986.60 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,330.2554 F2 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:44 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 3,897 | $101.09 | $393,947.73 |
DisclosureSEC source: 0001127602-22-011609 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,070.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:23 UTC |
Lynch Karen SDirector · President and CEO
|
GrantStock Option · Derivative | 171,517 | $101.09 Strike: $101.09 | $17,338,653.53 |
DisclosureSEC source: 0001127602-22-011633 · form4.xml · derivative · entry 3 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,517 Underlying: Common Stock · 171,517 shares Expires 2032-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:23 UTC |
Lynch Karen SDirector · President and CEO
|
Tax withholdingCommon Stock | 116,940 | $101.09 | $11,821,464.60 |
DisclosureSEC source: 0001127602-22-011633 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,090 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:24 UTC |
GUERTIN SHAWN MEVP & Chief Financial Officer
|
GrantStock Option · Derivative | 103,950 | $101.09 Strike: $101.09 | $10,508,305.50 |
DisclosureSEC source: 0001127602-22-011634 · form4.xml · derivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,950 Underlying: Common Stock · 103,950 shares Expires 2032-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:26 UTC |
Shah Prem SEVP and Co-President of Retail
|
GrantStock Option · Derivative | 41,580 | $101.09 Strike: $101.09 | $4,203,322.20 |
DisclosureSEC source: 0001127602-22-011635 · form4.xml · derivative · entry 8 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,580 Underlying: Common Stock · 41,580 shares Expires 2032-04-01 F6 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:26 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 3,731 | $101.09 | $377,166.79 |
DisclosureSEC source: 0001127602-22-011635 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:26 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 18,747 | $101.09 | $1,895,134.23 |
DisclosureSEC source: 0001127602-22-011635 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,324.24 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:28 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
GrantStock Option · Derivative | 77,962 | $101.09 Strike: $101.09 | $7,881,178.58 |
DisclosureSEC source: 0001127602-22-011636 · form4.xml · derivative · entry 4 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,962 Underlying: Common Stock · 77,962 shares Expires 2032-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:28 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Tax withholdingCommon Stock | 38,129 | $101.09 | $3,854,460.61 |
DisclosureSEC source: 0001127602-22-011636 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,183.3689 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:36 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 77,960 | $101.09 | $7,880,976.40 |
DisclosureSEC source: 0001127602-22-011639 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,855.059 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:39 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Option · Derivative | 46,777 | $101.09 Strike: $101.09 | $4,728,686.93 |
DisclosureSEC source: 0001127602-22-011640 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,777 Underlying: Common Stock · 46,777 shares Expires 2032-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:39 UTC |
Moriarty Thomas MEVP & General Counsel
|
Tax withholdingCommon Stock | 105,854 | $101.09 | $10,700,780.86 |
DisclosureSEC source: 0001127602-22-011640 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,897 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:41 UTC |
PELUSO MICHELLE AEVP and Co-President of Retail
|
GrantStock Option · Derivative | 57,172 | $101.09 Strike: $101.09 | $5,779,517.48 |
DisclosureSEC source: 0001127602-22-011643 · form4.xml · derivative · entry 3 PELUSO MICHELLE A · CIK 0001271739 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,172 Underlying: Common Stock · 57,172 shares Expires 2032-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2023. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:49 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionStock Option · Derivative | 5,346 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-010749 · form4.xml · derivative · entry 12 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,346 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: Option becomes exercisable in four equal installments commencing 04/01/2016. F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:49 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 5,346 | $104.70 | $559,726.20 |
DisclosureSEC source: 0001127602-22-010749 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071.24 Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:49 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionCommon Stock | 5,346 | $102.26 | $546,681.96 |
DisclosureSEC source: 0001127602-22-010749 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,417.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionStock Option · Derivative | 2,935 | $0.00 Strike: $104.82 | $0.00 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · derivative · entry 13 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935 Underlying: Common Stock · 2,935 shares Expires 2023-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Option becomes exercisable in four equal installments commencing 04/01/2017. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 2,935 | $106.65 | $313,017.75 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · nonDerivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071.24 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionCommon Stock | 2,935 | $104.82 | $307,646.70 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,006.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 1,689 | $106.65 | $180,131.85 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071.24 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:32 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 51,361 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-009725 · form4.xml · derivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,361 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:32 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 51,361 | $102.26 | $5,252,175.86 |
DisclosureSEC source: 0001127602-22-009725 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:32 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 51,361 | $105.00 | $5,392,905.00 |
DisclosureSEC source: 0001127602-22-009725 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836,751 Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:56 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 253 | $103.65 | $26,223.45 |
DisclosureSEC source: 0001127602-22-007421 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,668.2554 F2 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:56 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 183 | $103.65 | $18,967.95 |
DisclosureSEC source: 0001127602-22-007421 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,334.2554 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 23:04 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 141 | $103.65 | $14,614.65 |
DisclosureSEC source: 0001127602-22-007429 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,760.24 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 22:57 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
Tax withholdingCommon Stock | 5,233 | $104.30 | $545,801.90 |
DisclosureSEC source: 0001127602-22-007422 · form4.xml · nonDerivative · entry 1 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,754 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 22:58 UTC |
PELUSO MICHELLE AEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 12,609 | $104.30 | $1,315,118.70 |
DisclosureSEC source: 0001127602-22-007423 · form4.xml · nonDerivative · entry 1 PELUSO MICHELLE A · CIK 0001271739 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,911 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 23:04 UTC |
Shah Prem SEVP and Co-President of Retail
|
Tax withholdingCommon Stock | 226 | $104.30 | $23,571.80 |
DisclosureSEC source: 0001127602-22-007429 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,394.24 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:22 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantCommon Stock | 171,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006283 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,815.059 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:23 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantCommon Stock | 8,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006287 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,092.2554 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:25 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
GrantCommon Stock | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006288 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,713.9607 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:26 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
GrantCommon Stock | 85,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006291 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,312.3689 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:29 UTC |
Lynch Karen SDirector · President and CEO
|
GrantCommon Stock | 257,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006296 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,030 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:30 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock | 214,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006300 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836,751 F2 · shares: Represents shares earned by the reporting person pursuant to PSUs that were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.